A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients
Status:
Completed
Trial end date:
2017-07-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability, and pharmacokinetics of
ALN-AT3SC in healthy volunteers and Hemophilia A or B patients.